EyePoint Pharmaceuticals, Inc.
EYPT
$5.68
$0.1252.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 46.15% | -9.44% | -6.38% | -9.58% | 143.40% |
| Total Receivables | 60.58% | -72.51% | -54.39% | 274.53% | 66.67% |
| Inventory | -17.88% | -23.56% | -13.74% | 8.99% | -14.66% |
| Prepaid Expenses | -21.39% | 19.86% | -10.77% | 19.63% | -5.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.24% | 21.88% | -28.19% | 46.98% | 83.79% |
| Total Current Assets | 42.73% | -8.95% | -7.17% | -7.86% | 129.62% |
|
|
|||||
| Total Current Assets | 42.73% | -8.95% | -7.17% | -7.86% | 129.62% |
| Net Property, Plant & Equipment | -2.08% | 2.15% | 156.13% | 11.28% | 5.18% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 132.58% | 1,614.67% | 0.00% | 0.00% | 0.00% |
| Total Assets | 39.06% | -7.20% | -1.52% | -7.30% | 121.93% |
|
|
|||||
| Total Accounts Payable | 59.62% | -48.64% | 101.86% | 8.89% | -32.11% |
| Total Accrued Expenses | 29.30% | 9.39% | -16.90% | -8.86% | 26.63% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.97% | 5.13% | 2.91% | 95.03% | -46.79% |
| Total Finance Division Other Current Liabilities | -31.29% | -22.38% | -13.15% | -0.79% | -1.47% |
| Total Other Current Liabilities | -31.29% | -22.38% | -13.15% | -0.79% | -1.47% |
| Total Current Liabilities | 0.52% | -21.43% | -0.76% | -1.08% | -0.99% |
|
|
|||||
| Total Current Liabilities | 0.52% | -21.43% | -0.76% | -1.08% | -0.99% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.29% | -1.09% | 379.33% | -5.75% | -5.38% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -3.57% | -1.81% | -3.56% | -41.48% | -36.02% |
| Total Liabilities | -0.27% | -14.34% | 20.97% | -10.74% | -12.38% |
|
|
|||||
| Common Stock & APIC | 15.18% | 1.88% | 0.91% | 1.28% | 28.22% |
| Retained Earnings | -4.98% | -3.66% | -4.00% | -3.95% | -1.94% |
| Treasury Stock & Other | -12.21% | 47.85% | -5.26% | -3.24% | 2.73% |
| Total Common Equity | 53.84% | -4.19% | -8.65% | -6.15% | 354.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 53.84% | -4.19% | -8.65% | -6.15% | 354.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 53.84% | -4.19% | -8.65% | -6.15% | 354.31% |
|
|
|||||